Abstract
Purpose
To test the effects of the Relaxation Response Resiliency Program - Neurofibromatosis (3RP-NF), a mind-body resilience program for people with NF, on resilience factors from baseline to post-treatment and 6- and 12-month follow-up.
Methods
This is a secondary analysis of a fully powered randomized clinical trial (RCT) of 3RP-NF and health education control (HEP-NF). We recruited adults with NF1, NF2, or schwannomatosis who reported stress or difficulty coping with NF symptoms. Both conditions received 8 weekly 90-minute group sessions; 3RP-NF focused on building resilience skills. We measured resilience factors via the Measure of Current Status-A (adaptive coping), Cognitive and Affective Mindfulness Scale-Revised (mindfulness), Gratitude Questionnaire-6 (gratitude), Life Orientation Test Optimism Scale (optimism), and Medical Outcomes Study Social Support Survey (perceived social support) at baseline, post-intervention, and 6- and 12-month follow-up. We used linear mixed models with completely unstructured covariance across up to four repeated measurements (baseline, post-treatment, and 6- and 12-month follow-up) to investigate treatment effects on resilience factors.
Results
We enrolled 228 individuals (Mage=42.7, SD = 14.6; 74.5% female; 87.7% White; 72.8% NF1, 14.0% NF2, 13.2% schwannomatosis). Within groups, both 3RP-NF and HEP-NF showed statistically significant improvements in all outcomes across timepoints. 3RP-NF showed significantly greater improvement in adaptive coping compared to HEP-NF from baseline to post-intervention and baseline to 6 months (Mdifference= 0.29; 95% CI 0.13–0.46; p < 0.001; Mdifference= 0.25; 95% CI 0.07–0.33; p = 0.005); there were no other between-group differences amongst the remaining resilience factors.
Conclusion
3RP-NF showed promise in sustainably improving coping abilities amongst people with NF.
Trial registration Information
ClinicalTrials.gov Identifier: NCT03406208. Registration submitted December 6, 2017, first patient enrolled October 2017.
Similar content being viewed by others
References
Mayo Clinic (2023) Neurofibromatosis - Symptoms and causes. Mayo Clinic. https://www.mayoclinic.org/diseases-conditions/neurofibromatosis/symptoms-causes/syc-20350490. Accessed March 7,
Friedman JM (2002) Epidemiology of neurofibromatosis type 1. Am J Med Genet 89:1–6
Viskochil D, Buchberg AM, Xu G et al (1990) Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus. Cell 62(1):187–192. https://doi.org/10.1016/0092-8674(90)90252-A
Lin AL, Gutmann DH (2013) Advances in the treatment of neurofibromatosis-associated tumours. Nat Rev Clin Oncol 10(11):616–624. https://doi.org/10.1038/nrclinonc.2013.144
Vranceanu AM, Merker VL, Park E, Plotkin SR (2013) Quality of life among adult patients with neurofibromatosis 1, neurofibromatosis 2 and schwannomatosis: a systematic review of the literature. J Neurooncol 114(3):257–262. https://doi.org/10.1007/s11060-013-1195-2
Wang DL, Smith KB, Esparza S et al (2012) Emotional functioning of patients with neurofibromatosis tumor suppressor syndrome. Genet Med 14(12):977–982. https://doi.org/10.1038/gim.2012.85
Fishbein NS, Vranceanu AM, Mace RA (2022) Baseline characteristics of adults with neurofibromatosis enrolled on a psychosocial randomized controlled trial. J Neurooncol 159(3):637–646. https://doi.org/10.1007/s11060-022-04104-6
Szanton SL, Gill JM (2010) Facilitating resilience using a society-to-cells Framework: a theory of nursing essentials Applied to Research and Practice. Adv Nurs Sci 33(4):329. https://doi.org/10.1097/ANS.0b013e3181fb2ea2
Cal SF, de Sá LR, Glustak ME, Santiago MB (2015) Resilience in chronic diseases: a systematic review. Cogent Psychol 2(1):1024928. https://doi.org/10.1080/23311908.2015.1024928
Ovaska-Stafford N, Maltby J, Dale M (2021) Literature Review: psychological resilience factors in people with neurodegenerative Diseases. Arch Clin Neuropsychol 36(2):283–306. https://doi.org/10.1093/arclin/acz063
Folkman S, Moskowitz JT (2004) Coping: pitfalls and promise. Annu Rev Psychol 55:745–774. https://doi.org/10.1146/annurev.psych.55.090902.141456
Creswell JD (2017) Mindfulness interventions. Annu Rev Psychol 68:491–516. https://doi.org/10.1146/annurev-psych-042716-051139
Pentz M (2005) Resilience among older adults with cancer and the importance of social support and spirituality-faith. J Gerontol Soc Work 44:3–22
Carver CS, Scheier MF, Segerstrom SC (2010) Optimism. Clin Psychol Rev 30:879–889
Horton TV, Wallander JL (2001) Hope and social support as resilience factors against psychological distress of mothers who care for children with chronic physical conditions. Rehabil Psychol 46:382–399
Tsai J, Harpaz-Rotem I, Pietrzak RH, Southwick SM (2012) The role of coping, resilience, and social support in mediating the relation between PTSD and social functioning in veterans returning from Iraq and Afghanistan. Psychiatry 75:135–149
Meyers EE, Presciutti A, Shaffer KM et al (2020) The impact of resilience factors and anxiety during hospital admission on longitudinal anxiety among dyads of Neurocritical Care Patients without Major Cognitive Impairment and their family caregivers. Neurocrit Care 33(2):468–478. https://doi.org/10.1007/s12028-020-00913-7
Borrell-Carrió F, Suchman AL, Epstein RM (2004) The biopsychosocial model 25 years later: principles, practice, and scientific inquiry. Ann Fam Med 2(6):576–582. https://doi.org/10.1370/afm.245
Carlson LE, Bultz BD (2003) Benefits of psychosocial oncology care: improved quality of life and medical cost offset. Health Qual Life Outcomes 1:8. https://doi.org/10.1186/1477-7525-1-8
Samuelson M, Foret M, Baim M et al (2010) Exploring the effectiveness of a comprehensive mind-body intervention for medical symptom relief. J Altern Complement Med 16(2):187–192. https://doi.org/10.1089/acm.2009.0142
Vranceanu AM, Gonzalez A, Niles H et al (2014) Exploring the effectiveness of a modified comprehensive mind-body intervention for Medical and Psychologic Symptom Relief. Psychosomatics 55(4):386–391. https://doi.org/10.1016/j.psym.2014.01.005
Vranceanu AM, Merker VL, Plotkin SR, Park ER (2014) The relaxation response resiliency program (3RP) in patients with neurofibromatosis 1, neurofibromatosis 2, and schwannomatosis: results from a pilot study. J Neurooncol 120(1):103–109. https://doi.org/10.1007/s11060-014-1522-2
Vranceanu AM, Riklin E, Merker VL, Macklin EA, Park ER, Plotkin SR (2016) Mind-body therapy via videoconferencing in patients with neurofibromatosis: an RCT. Neurology 87(8):806–814. https://doi.org/10.1212/WNL.0000000000003005
Vranceanu AM, Manglani HR, Choukas NH et al (2023) Mind-body skills training for geographically diverse adults with neurofibromatosis: a fully remote randomized clinical trial. Manuscr under Rev JAMA Netw Open 6(6):e2320599
Cohen S (1988) Perceived stress in a probability sample of the United States. The Social psychology of Health. Sage Publications, Inc., pp 31–67
Cohen S, Kamarck T, Mermelstein R (1983) A global measure of perceived stress. J Health Soc Behav 24(4):385–396
Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG (2009) Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 42(2):377–381. https://doi.org/10.1016/j.jbi.2008.08.010
Carver CS, Measure of Current Status (2006) https://local.psy.miami.edu/faculty/ccarver/sclMOCS.phtml. Accessed March 7, 2023
Feldman G, Hayes A, Kumar S, Greeson J, Laurenceau JP (2007) Mindfulness and emotion regulation: the Development and initial validation of the cognitive and affective mindfulness scale-revised (CAMS-R). J Psychopathol Behav Assess 29(3):177–190. https://doi.org/10.1007/s10862-006-9035-8
Mccullough ME, Emmons RA, Tsang J-A (2002) The grateful disposition: a conceptual and empirical topography. J Pers Soc Psychol 82:112–127
Scheier MF, Carver CS (1985) Optimism, coping, and health: assessment and implications of generalized outcome expectancies. Health Psychol 4:219–247
Sherbourne CD, Stewart AL (1991) The MOS social support survey. Soc Sci Med 32:705–714
Vranceanu AM, Zale EL, Funes CJ et al (2018) Mind-body treatment for International English-Speaking adults with neurofibromatosis via live videoconferencing: protocol for a single-blind randomized controlled trial. JMIR Res Protoc 7(10):e11008. https://doi.org/10.2196/11008
Park ER, Traeger L, Vranceanu AM et al (2013) The development of a patient-centered program based on the relaxation response: the Relaxation Response Resiliency Program (3RP). Psychosomatics 54(2):165–174. https://doi.org/10.1016/j.psym.2012.09.001
Benson H, Rosner BA, Marzetta BR, Klemchuk HM (1974) Decreased blood-pressure in pharmacologically treated hypertensive patients who regularly elicited the relaxation response. Lancet Feb 23(7852):289–291. https://doi.org/10.1016/s0140-6736(74)92596-3
Benson H, Klemchuk HP, Graham JR (1974) The usefulness of the relaxation response in the therapy of headache. Headache 14(1):49–52. https://doi.org/10.1111/j.1526-4610.1974.hed1401049.x
Benson H, Rosner BA, Marzetta BR, Klemchuk HP (1974) Decreased blood pressure in borderline hypertensive subjects who practiced meditation. J Chronic Dis 27(3):163–169. https://doi.org/10.1016/0021-9681(74)90083-6
Beary JF, Benson H (1974) A simple psychophysiologic technique which elicits the hypometabolic changes of the relaxation response. Psychosom Med 36(2):115–120. https://doi.org/10.1097/00006842-197403000-00003
Peters RK, Benson H, Peters JM (1977) Daily relaxation response breaks in a working population: II. Effects on blood pressure. Am J Public Health 67(10):954–959. https://doi.org/10.2105/ajph.67.10.954
Greenwood MM, Benson H (1977) The efficacy of progressive relaxation in systematic desensitization and a proposal for an alternative competitive response–the relaxation response. Behav Res Ther 15(4):337–343. https://doi.org/10.1016/0005-7967(77)90065-1
Benson H, Klipper M (2000) Relaxation response. HarperCollins Publishers
Dusek JA, Otu HH, Wohlhueter AL et al (2008) Genomic counter-stress changes induced by the relaxation response. PLoS ONE 3(7):e2576. https://doi.org/10.1371/journal.pone.0002576
Mahaffey BL, Mackin DM, Vranceanu AM et al (2020) The Stony Brook Health Enhancement Program (SB-HEP): the development of an active control Condition for mind-body interventions. J Health Psychol 25(13–14):2129–2140. https://doi.org/10.1177/1359105318787024
Benjamini Y, Hochberg Y (1995) Controlling the false Discovery rate: a practical and powerful Approach to multiple testing. J Roy Stat Soc: Ser B (Methodol) 57(1):289–300. https://doi.org/10.1111/j.2517-6161.1995.tb02031.x
Little RJ, Rubin DB (2002) Missing data in experiments. Stat Anal missing data Aug 26:24–40
Scarf D, Moradi S, McGaw K et al (2016) Somewhere I belong: long-term increases in adolescents’ resilience are predicted by perceived belonging to the in-group. Br J Soc Psychol 55(3):588–599. https://doi.org/10.1111/bjso.12151
Slavich GM, Roos LG, Zaki J (2022) Social belonging, compassion, and kindness: key ingredients for fostering resilience, recovery, and growth from the COVID-19 pandemic. Anxiety Stress Coping 35(1):1–8. https://doi.org/10.1080/10615806.2021.1950695
Muldoon OT, Haslam SA, Haslam C, Cruwys T, Kearns M, Jetten J (2019) The social psychology of responses to trauma: social identity pathways associated with divergent traumatic responses. Eur Rev Social Psychol 30(1):311–348. https://doi.org/10.1080/10463283.2020.1711628
Steinhardt M, Dolbier C (2008) Evaluation of a resilience intervention to enhance coping strategies and protective factors and decrease symptomatology. J Am Coll Health 56(4):445–453. https://doi.org/10.3200/JACH.56.44.445-454
Tait L, Birchwood M, Trower P (2004) Adapting to the challenge of psychosis:personal resilience and the use of sealing-over (avoidant) coping strategies. Br J Psychiatry 185:410–415. https://doi.org/10.1192/bjp.185.5.410
Acknowledgements
This study was funded by a clinical trial grant awarded to AMV by the Department of Defense (DOD; W81XWH-17-1-0121). The sponsor was not involved in the review or approval of this manuscript for publication. We thank the study participants, Children’s Tumor Foundation, and NF chapter and organizations that aided with recruitment.
Author information
Authors and Affiliations
Contributions
AMP: design, drafting of main text, critical revisions; EGL: data acquisition, drafting of main text, critical revisions; ECW: drafting of main text, critical revisions, preparation of references and figures; JG: drafting of main text, critical revisions; JB: design, data analysis, drafting of main text, critical revisions; JEH: drafting of abstract, critical revisions; KAM: drafting of abstract, critical revisions; AMV: conceptualization, design, data acquisition, critical revisions.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Presciutti, A.M., Lester, E.G., Woodworth, E.C. et al. The impact of a virtual mind-body program on resilience factors among international English-speaking adults with neurofibromatoses: secondary analysis of a randomized clinical trial. J Neurooncol 163, 707–716 (2023). https://doi.org/10.1007/s11060-023-04389-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11060-023-04389-1